132 related articles for article (PubMed ID: 35256763)
1. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
Huang Y; Chen M; Yang C; Ruan J; Wang S; Han B
Leukemia; 2022 May; 36(5):1351-1360. PubMed ID: 35256763
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
Long Z; Yu F; Du Y; Li H; Chen M; Zhuang J; Han B
Ann Hematol; 2018 Nov; 97(11):2047-2054. PubMed ID: 29982851
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia].
Zhang RX; Huang YZ; Han B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1138-1142. PubMed ID: 37551489
[TBL] [Abstract][Full Text] [Related]
4. Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Chen Z; Liu X; Chen M; Yang C; Han B
Ann Hematol; 2020 Apr; 99(4):737-741. PubMed ID: 32030447
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report.
Huang Y; Jiang X; Han B
Ther Adv Hematol; 2020; 11():2040620720940144. PubMed ID: 32733663
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
Chen Z; Chen M; Yang C; Han B
Ann Hematol; 2020 Jul; 99(7):1485-1491. PubMed ID: 32488602
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Sawada K; Hirokawa M; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2007 Aug; 92(8):1021-8. PubMed ID: 17640861
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
9. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Wu X; Wang S; Lu X; Shen W; Qiao C; Wu Y; Lu R; Wang S; Zhang J; Hong M; Zhu Y; Li J; He G
Int J Hematol; 2018 Aug; 108(2):123-129. PubMed ID: 29589280
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis.
Lobbes H; Lega JC; Le Guenno G; Ruivard M; Mainbourg S
Blood Adv; 2023 Nov; 7(21):6451-6465. PubMed ID: 37624775
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A Reversed Chemoresistance of a Patient with Pure Red Cell Aplasia Secondary to Thymoma.
Li P; Du F; Gong Z; Hu B; Chi C; Chu H; Chen J
Anticancer Res; 2017 Aug; 37(8):4611-4614. PubMed ID: 28739760
[TBL] [Abstract][Full Text] [Related]
12. Acquired pure red cell aplasia in a child.
Sharma RA; Hiwarkar P; Manglani MV; Muralidhar HP
J Postgrad Med; 2002; 48(1):37-8. PubMed ID: 12082327
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.
Zhang Z; Hu Q; Yang C; Chen M; Han B
Ann Med; 2023; 55(2):2282180. PubMed ID: 37967535
[TBL] [Abstract][Full Text] [Related]
14. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
Yang L; Niu H; Zhang T; Cao Q; Liu M; Liu Y; Yan L; Qi W; Wang T; Liu C; Li L; Xing L; Wang H; Shao Z; Fu R
Ann Hematol; 2024 Jun; 103(6):1877-1885. PubMed ID: 38308019
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
17. Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids.
Wu X; Yang Y; Lu X; Yin H; Wang S; Wang S; Hong M; Zhu Y; Lu R; Qiao C; Wu Y; He G; Li J
Medicine (Baltimore); 2019 Oct; 98(41):e17425. PubMed ID: 31593095
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.
Sato A; Sano F; Ishii T; Adachi K; Negishi R; Matsumoto N; Okuse C
Clin J Gastroenterol; 2014 Feb; 7(1):74-8. PubMed ID: 24523831
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pure red-cell aplasia with cyclosporine in a renal transplant patient.
Yildirim R; Bilen Y; Keles M; Uyanik A; Gokbulut P; Aydinli B
Exp Clin Transplant; 2013 Feb; 11(1):63-5. PubMed ID: 22891934
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia.
Grigg AP; O'Flaherty E
Leuk Lymphoma; 2001; 42(6):1339-42. PubMed ID: 11911417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
